Researcher

    Thuy Mai Luu , M.D. , M.Sc.

    thuy.mai.luu@umontreal.ca
    Thuy Mai Luu
    Research Axis
    Fetomaternal and Neonatal Pathologies
    Research Theme
    Fetal development and prematurity
    Address
    CHUSJ

    Phone
    514 345-4931, ext. 6642

    Fax
    514-345-4822

    Online

    Title

    • Deputy Head, Research Axis, Fetomaternal and Neonatal Pathologies, CHU Sainte-Justine Research Center 
    • Clinician-scientist, CHU Sainte-Justine Research Center
    • Pediatrician, Department of Pediatrics, CHU Sainte-Justine
    • Clinical Assistant Professor, Department of Pediatrics, University of Montreal

    Education

    • MSc in Epidemiology, McGill University, 2009
    • Fellowship in Medical and Neurodevelopmental Follow-Up of At-Risk Newborns, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island, USA, 2008
    • Residency in Pediatrics, CHU Sainte-Justine, University of Montreal, 2006
    • MD, McGill University, 2001

    Research Interests

    I’m a paediatrician and clinical researcher at the Neonatal Follow-Up Clinic of CHU Sainte-Justine. My research focuses on long-term neurodevelopmental and physical health outcomes following preterm birth, from infancy to adulthood, looking a risk and resiliency factors along with best screening strategies to enhance clinical follow-up. We are following a cohort of young adults born preterm (HAPI – Health of Adults born Preterm Investigation) that allows us to identify innovative biomarkers and to study intervention such as exercise training for preventative purposes. With a multidisciplinary team, I have also developed a web-based health literacty platform - Mieux Agir au Quotidien - for parents of children born preterm to enhance knowledge transfer. I closely work with the Canadian Neonatal Follow-Up Network (CNFUN) for epidemiological studies and to better define health care needs of families of preterm infants.

    Awards and Distinctions

    • Clinical Research Scholars - Junior 1, Fonds de recherche du Québec - Santé (FRQS), 2013-2017
    • 1st Award for the New England Resident Research Competition, New England Perinatal Society, US, 2008

    Presentations

    • «Health of Adults born Preterm Investigation». Annual Meeting of the Adult Preterm International Collaboration, San Francisco, May 2017
    •  «Suivi périodique de l’enfant né entre 32 et 36 semaines d’âge gestationnel durant sa première année de vie». Conférence Pédiatrie de première ligne du Centre hospitalier universitaire Sainte-Justine, Montréal, November 2016
    • «Naître prématurément et impacts à long terme sur la santé». Journée scientifique du Département de pédiatrie de l’Université Sherbrooke, October 2015
    • «An educational program of developmentally-supportive care for parents of preterm infants». Canadian Perinatal National Research Meeting, Montebello, February 2015
    • «Dépistage des problèmes de développement en clinique: des outils simples pour vous faciliter la vie». Congrès Annuel de la Société Canadienne de Pédiatrie, Montréal, June 2014

    Most Important Publications

    1. Luu TM, Rehman Mian MO, Nuyt AM. Long-Term Impact of Preterm Birth: Neurodevelopmental and Physical Health Outcomes. Clin Perinatol. 2017 Jun;44(2):305-314. PMID: 28477662
    2. Bertagnolli M, Nuyt AM, Thébaud B, Luu TM. Endothelial Progenitor Cells as Prognostic Markers of Preterm Birth-Associated Complications. Stem Cells Transl Med. 2017 Jan;6(1):7-13. PMID:28170188
    3. Synnes A, Luu TM, Moddemann D, Church P, Lee D, Vincer M, Ballantyne M, Majnemer A, Creighton D, Yang J, Sauve R, Saigal S, Shah P, Lee SK; Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network. Determinants of developmental outcomes in a very preterm Canadian cohort. Arch Dis Child Fetal Neonatal Ed. 2017 May;102(3):F235-F234. PMID: 27758929
    4. Beaulieu-Poulin C, Simard MN, Babakissa H, Lefebvre F, Luu TM. Validity of the language development survey in infants born preterm. Early Hum Dev. 2016 Jul;98:11-6. PMID: 27351348
    5. Morin J, Luu TM, Superstein R, Ospina LH, Lefebvre F, Simard MN, Shah V, Shah PS, Kelly EN; Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network Investigators. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity. Pediatrics. 2016 Apr;137(4). pii: e20153218. PMID: 27244705
    6. Luu TM, Katz SL, Leeson P, Thébaud B, Nuyt AM. Preterm birth: risk factor for early-onset chronic diseases. CMAJ. 2016 Jul 12;188(10):736-46. PMID: 26644500
About this page
Edited by Hoffmann Maude

Created on 9/18/2014
Alert or send a suggestion

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931

Légal

© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine